Benign prostatic hyperplasia
Individual solutions. For a growing problem.
The benign prostatic syndrome (BPS) is caused by an innocuous enlargement of the prostate and characterised by a weakened urinary stream, the urge to void, nightly urination or the feeling of incomplete emptying of the bladder after urination. These symptoms influence the affected person‘s quality of life and also have an effect on his social environment. In the most cases, the first form of treatment is by means of medications, i. e. plant-based products or preparations that intervene in the nerve conduction and / or metabolism of the prostate gland. It has also repeatedly been possible to achieve success through medications that are actually intended for other purposes: This may be in the form of studies or based on knowledge from recently published studies.
If a reduction in the size of the prostate gland becomes necessary in cases of failure or intolerance of medications, this is almost exclusively performed by means of minimally invasive surgery. In addition to the electrosurgery that has been further developed with the support of the regional industry, laser and other procedures with mechanically oriented techniques are used. The latest developments in this area show that injections into the prostate gland or the insertion of mechanical support structures can achieve a good result for urination in some cases.
Left side: Prostatic hyperplasia with constriction of the urethra.
Right side: Minimally invasive prostate retractors for therapy of the benign prostatic syndrome.
It is not always possible for these new techniques to achieve the same results as tissue removal, which is seen as the gold standard. However, they offer the advantage that some of them can be performed without anaesthesia and with a distinctly lower risk of bleeding. This allows the clinic to do justice to its function as the contact point for patients with accompanying diseases or even rare medical findings.